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A b s t r a c t
Background: Psychosocial stress has been hypothesized to impact renal changes,
but this hypothesis has not been adequately tested. The aim of this study was to
examine the relationship between psychosocial stress and estimated glomerular
ﬁltration rate (eGFR) and to examine other predictors of eGFR changes among
persons with diabetes mellitus (DM).
Methods: Data from a survey conducted in 2005 by a major health maintenance
organization located in the southeastern part of the United States, linked to patients’
clinical and pharmacy records (n¼575) from 2005 to 2008, was used. Study participants
were working adults aged 25–59 years, diagnosed with DM but without advanced
microvascular or macrovascular complications. eGFR was estimated using the Modiﬁca-
tion of Diet in Renal Disease equation. A latent psychosocial stress variable was created
from ﬁve psychosocial stress subscales. Using a growth factor model in a structural
equation framework, we estimated the association between psychosocial stress and
eGFR while controlling for important covariates.
Results: The psychosocial stress variable was not directly associated with eGFR in the
ﬁnal model. Factors found to be associated with changes in eGFR were age, race, insulin
use, and mean arterial pressure.
Conclusion: Among fairly healthy DM patients, we did not ﬁnd any evidence of a direct
association between psychosocial stress and eGFR changes after controlling for
important covariates. Predictors of eGFR change in our population included age, race,
insulin use, and mean arterial pressure.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Reduced renal function, which may progress to diabetic
nephropathy (DN), is a major cause of mortality among diabetes
mellitus (DM) patients [1,2]. An earlier study has demonstrated
that mortality rate among type 1 DM patients without kidney
disease approaches individuals free of the condition [3]. With an
estimated quarter to a third of individuals with DM likely to
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develop DN [4–6], it is crucial to understand the predictors of
renal decline to minimize their occurrence and ultimately, reduce
chronic kidney disease among individuals with DM.
Among DM patients, tight glycemic control decreases the risk
of decline of renal function and slows the progression of DN [7,8].
However, some DM patients with poor glycemic control never
develop DN, whereas some with good glycemic control progress
to DN [5]. Such occurrence indicates that factors other than
glycemic control may be important for decline of renal function
and subsequent progression to DN. One obvious candidate has
been genetic factors because there is a strong familial risk for DN;
however, there has been limited success in identifying speciﬁc
genes that account for such predisposition among large DM
population [9,10]. Other traditional risk factors inﬂuencing the
initiation, sustenance, and progression of DN include high blood
pressure and smoking [11–13]. For instance, hypertension is
estimated to be present in 80% of patients with kidney diseases
[14]. However, the variability in the onset and progression of DN
has not been fully explained as a function of the group differences
in the aforementioned traditional risk factors alone [5]. Some
nontraditional risk factors proposed to inﬂuence the renal decline
in the general population include psychosocial stress, oxidative
stress, advanced glycation end-products, and activation of protein
kinase C [15–17]. The relationship between psychosocial stress
and decline of renal function among DM patients has not been
adequately investigated, which is the reason for the current study.
Psychosocial stress has been suspected as a potential factor in
decline of renal function because of its established relationship
with glycemic control, hypertension, and smoking [18–21].
Another proposed link between psychosocial stress and decline
of renal function is through the increased engagement in beha-
viors that increase the risk of renal damage such as alcohol abuse,
smoking, and drug abuse [15,22–24]. Although higher levels of
psychosocial stress have been associated with overall poor health,
high blood pressure, poor glycemic control, and smoking [18,25–
29], the direct association between psychosocial stress and
decline in renal function has not been adequately examined.
The primary aim of the present study was therefore to
examine the direct relationship between psychosocial stress
and renal function over time among individuals with DM.
Although factors including glycemic control, blood pressure,
smoking, and other sociodemographic factors have been
associated with decline of renal function, the course of
estimated glomerular ﬁltration rate (eGFR) among DM
patients can be complex and heterogeneous and may be
affected by multiple factors including existing comorbid
conditions [30]. For instance, albuminuria was identiﬁed as
the strongest predictor of eGFR decline among Caucasians
with DM [31], whereas among Japanese with DM, higher
glycemic levels were the strongest predictor [32]. Owing to
the variability in eGFR trajectory among different popula-
tions, our secondary study aim was to explore other docu-
mented predictors of decline of renal function among our
unique study population.
Methods
Study population
We used data from a survey conducted in 2005 by a major
health management organization (HMO) in the southeastern
part of the United States that collected information on health
and healthy behaviors. Study participants were working adults
who, at the time of the survey in 2005, met the following
inclusion criteria: (1) age 25–59 years; (2) employed by one of
the 100 largest private or public employer groups offering the
HMO as an insurance option; (3) enrolled in the HMO;
(4) subscriber within the enrolled family; and (5) diagnosed
with DM but without any of the following complications from
diabetes—microalbuminuria or macroalbuminuria, overt pro-
teinuria, retinopathy, nephropathy, and/or neuropathy.
Only individuals who reported their race as African American
(black) or Caucasian (white) were included in the present study
because other racial/ethnic groups represented a very small
proportion of the HMO enrollees. The Institutional Review Board
of the HMO reviewed and approved the study protocol.
Data and measures
The survey instrument included items and scales that had
previously been used in other studies and which had demon-
strated reliability and validity [33,34]. The survey was con-
ducted once during 2005. Participants' 4-year clinical and
pharmacy records from 2005 to 2008 were linked to their
2005 survey data.
Dependent variable
The main dependent variable was eGFR. Using the serum
creatinine, the annual eGFR was estimated using the Modiﬁca-
tion of Diet in Renal Diseases equation [35].
eGFR¼ 186 SCr1:154  Age0:203  ½1:210 if black
½0:742 if f emale ð1Þ
Main independent variable
The main independent variable was psychosocial stress,
assessed from social settings (family and friends) and the work
environment. Social stress was assessed by two 4-item subscales:
one reﬂecting friend/family support and the other measuring
friend/family strain. The instrument was adapted from the Midlife
in the United States (MIDUS) study [33]. The MIDUS study scales
for family and friends are identical except for the reference (e.g.,
“How much do members of your family really care about you?”
and “How much do your friends really care about you?”); there-
fore, we combined the references to create a single measure of
social climate (e.g., “How much do your friends and family
members really care about you?”). Each subscale was averaged
and scaled from 0 (most strained, least supportive) to 100 (least
strained, most supportive). The work-related psychosocial stress
was assessed using the following four subscales from the MIDUS
study [33]: work decision authority (6 items), job demands (5
items), coworker support (2 items), and supervisor support (3
items). Each itemwas assessed using a 5-response Likert scale: “all
of the time,” “most of the time,” “sometimes,” “rarely,” and
“never.” Each subscale was averaged and scaled from 0 (most
strained, least supportive) to 100 (least strained, most supportive)
by transforming each item response from 0 to 100 (and reverse
coding where necessary).
Health-related covariates
Glycemic control was assessed using hemoglobin A1c
(HbA1c) measures from participants' laboratory results from
2005 through 2008. Data on height, weight, systolic blood
pressure, and diastolic blood pressure were obtained from
medical records associated with participants' primary care
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visits. Height and weight were used to compute body mass
index. Systolic and diastolic blood pressures were used to
compute mean arterial pressure (MAP). A binary variable was
created to indicate insulin use versus insulin nonuse. For
individuals using oral hypoglycemic agents (OH), we estimated
and included the proportion of days in 2005 with OH coverage.
Other sociodemographic measures
Participants' age (ranging between 25 years and 59 years) and
sex (male¼0 and female¼1) were assessed from the HMO's
computerized data. Race/ethnicity (black¼0 and white¼1), level
of formal education (high school education or less¼0, some
college¼1, college graduate¼2, and postgraduate¼3), and mar-
ital status (married¼0 and not married¼1) were assessed from
the survey. Individual-level income information was generally
not available and was not included in this study as a covariate.
Instead, we used the neighborhood-based socioeconomic status,
a validated census track-level scale comprised of seven measures
from the US Census as described by Roblin [34].
Statistical analysis
The percent missing on covariates ranged between 0% and
41%, and the percent pairwise coverage for the covariates
ranged between 0.39 and 1.00. The percent missing for the
stress indicators ranged between 0.5% and 1.6% with covar-
iance coverage ranging between 0.98 and 1.00. For eGFR
measures, 49% had a measure on all four waves, whereas
91% had a measure on at least two waves. To address the
missing values on exogenous predictors, we performed multi-
ple imputations (10 times) in SAS for the measurement and
the growth models. Descriptive statistics was performed in
SAS software, version 9.3 (SAS Institute Inc., Cary, NC, USA)
[36], while all the other analyses were performed in
Mplus statistical software, version 6.1 (Muthén & Muthén,
Los Angeles, CA, USA) [37]. Latent psychosocial stress variable
was speciﬁed using conﬁrmatory factor analysis (CFA) by
loading the stress subscales on the latent stress variable
(Fig. 1). Bivariate regression analysis was performed between
the latent psychosocial stress and selected covariates including
age, race, insulin use, and MAP. An unconditional growth
model was ﬁt to the four eGFR waves. Without a priori
hypothesis about the functional form of the relationship
between psychosocial stress and eGFR over time, stress was
speciﬁed with direct effects on the repeated measures to allow
for the greatest ﬂexibility to obtain a time-varying effect
estimates in the ﬁnal growth model (Fig. 1). We controlled
for HbA1c measures, sociodemographic variables (sex, age,
race, education, neighborhood-based socioeconomic status),
smoking, body mass index, insulin use, medication coverage
(proportion of days covered by OH), and MAP. Study partici-
pants were grouped into two—those who experienced decline
in eGFR and those who did not and subgroup analysis was
performed for the two groups. The robust maximum like-
lihood estimator was used. All statistical signiﬁcance was
determined at a two-sided alpha level of 0.05.
Results
Descriptive statistics
The study included 575 participants with the mean age of
49.6 7 6.9 years. As indicated by Table 1, slightly higher
Psychosocial
stress
*A1c05
†eGFR5
1 1 1 1 0 1 2 3
Slope
eGFR
Intercept
eGFR
†eGFR6 †eGFR7 †eGFR8
*A1c06 *A1c07 *A1c08
Age, sex, education,
BMI, smoke, MAP,
Med coverage,
insulin use
‡Coworker
§Supervisor
Demand
¶Decision
Social
Figure 1. Graphical representation of the ﬁnal growth model.
* A1c05–A1c08: Glycosylated hemoglobin measure from 2005 to 2008, respectively.
† eGFR5–eGFR8: estimated glomerular ﬁltration rate from 2005 to 2008, respectively.
‡ Coworker support.
§ Supervisor support.
‖ Job demand.
¶ Work decision authority.
A1c, glycosylated hemoglobin; BMI, body mass index; eGFR, estimated glomerular ﬁltration rate; MAP, mean arterial pressure; Med Coverage, oral
hypoglycemic agents coverage during 2005.
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proportions of the study sample were women and blacks.
Individuals included in the study were highly educated, and
the majority was married. The prevalence of current smoking
was 16%. The mean eGFR at baseline was 83.2 mL/min/1.73 m2
(standard deviation¼21.3), whereas the mean psychosocial
stress for the subscales ranged between 47.1 and 66.0 (Table 2).
Approximately 30% (173) of the participants experienced a
decline in eGFR, whereas the remaining 70% (402) had their
eGFR remain the same or improved during the study period. In
the bivariate analysis, other than age, none of the other
variables (MAP, race, and insulin use) was signiﬁcantly asso-
ciated with psychosocial stress.
The measurement and the growth models
Measurement model
Using supervisor support to scale the factors, the unstan-
dardized factor loadings ranged between 0.106 and 0.787
(Table 3). The mean ﬁt indices for the CFA were as follows:
χ2 Po0.001, root mean square error of approximation
(RMSEA)¼0.072 [90% conﬁdence interval (CI)¼0.041–0.107],
comparative ﬁt index (CFI)¼0.951, Tucker Lewis index (TLI)¼
0.902, and standardized root mean square residual (SRMR)¼
0.037. The mean factor score determinacy coefﬁcient was
0.873, with values ranging between 0.869 and 0.878. The
mean standardized residual variances of the stress subscales
were all signiﬁcant, with values ranging between 0.35 (super-
visor support) and 0.99 (work demand; Table 3).
Structural model
The baseline model estimated an intercept parameter with
time centered at 2005 (baseline) and a slope parameter that
represented the mean annual rate of eGFR change during the
study period. The model ﬁt was adequate: χ2 P40.001,
RMSEA¼0.058 (90% CI¼0.061–0.094), CFI¼0.94, TLI¼0.926,
and SRMR¼0.037. Signiﬁcant variance existed in the intercept
(σ2¼360.77, Po0.001) and the slope (σ2¼10.49, Po0.016)
parameters. The mean intercept was 82.62, whereas the mean
slope was 0.88 (P¼0.003). Table 3 contains both the unstan-
dardized and the standardized estimates of the CFA model.
The ﬁt for the ﬁnal conditional model to estimate the direct
association between psychosocial stress and eGFR was ade-
quate: χ2 P40.001, RMSEA¼0.048 (90% CI¼0.041–0.055),
CFI¼0.916, TLI¼0.893, and SRMR¼0.037. Psychosocial stress
was not directly associated with any of the four measures of
the eGFR. At the study baseline, age, race, MAP, and insulin use
were signiﬁcantly associated with eGFR. Over time, MAP was
Table 2. Health status–related characteristics of study sample
Variable Mean (SD)
Stress subscales (2005)
Decision latitude 58.5 (24.4)
Work demands 47.1 (18.6)
Coworker support 60.3 (21.8)
Supervisor support 62.5 (24.1)
Social stress 66.0 (17.8)
eGFR
Year 2005 83.2 (21.3)
Year 2006 82.5 (25.2)
Year 2007 81.8 (22.0)
Year 2008 82.3 (23.3)
HbA1c
Year 2005 8.1 (1.8)
Year 2006 8.0 (1.9)
Year 2007 7.9 (1.7)
Year 2008 8.0 (1.7)
BMI (2005) 34.3 (7.3)
MAP (2005) 114.3 (13.5)
Proportion of days covered by oral agents in 2005 0.79 (0.3)
BMI, body mass index; eGFR, estimated glomerular ﬁltration rate;
HbA1c, hemoglobin A1c; MAP, mean arterial pressure; SD, standard
deviation.
Table 3. Estimates from the CFAn and the unconditional growth
models†
Estimate SE P Standardized
estimate
Stress subscale
Supervisor support 1.00 0.00 NA 0.81
Coworker support 0.79 0.09 <0.001 0.71
Decision latitude 0.55 0.08 <0.001 0.44
Work demand 0.11 0.05 0.046 0.11
Social stress 0.26 0.06 <0.001 0.29
Residual variances
Supervisor support 203.91 44.35 <0.001 0.35
Coworker support 239.39 26.47 <0.001 0.50
Decision latitude 479.12 33.85 <0.001 0.81
Work demand 340.04 17.71 <0.001 0.99
Social stress 270.85 19.06 <0.001 0.92
eGFR intercept factor
Mean 82.62 0.88 <0.001 4.351
Variance 360.77 4.34 <0.001 1.00
eGFR slope factor
Mean 0.88 0.30 0.003 0.28
Variance 10.49 4.34 0.016 1.00
Intercept/slope
covariance
2.63 8.29 0.751 0.05
n Mean ﬁt indices for CFA model: χ2 P40.001; RMSEA 0.072 (90%
CI¼0.041–0.107); CFI¼0.951; TLI¼0.902; and SRMR¼0.037. † Mean ﬁt
indices for unconditional growth model: χ2 P40.001; RMSEA¼0.058
(90% CI¼0.061–0.094); CFI¼0.938; TLI¼0.926; SRMR¼0.037.
CFA, conﬁrmatory factor analysis; CFI, comparative ﬁt index; CI, con-
ﬁdence interval; eGFR, estimated glomerular ﬁltration rate; RMSEA, root
mean square error of approximation; SE, standard error; SRMR, stan-
dardized root mean square residual; TLI, Tucker Lewis index.
Table 1. Selected characteristics of the study sample
Demographic variable (n¼575) % (n)
Age (y), 2005 49.6 (6.9)n
Sex
Male 40.7 (234)
Female 59.3 (341)
Race
White 45.9 (264)
Black 54.1 (311)
Education
Less than HS 5.0 (29)
HS grad 19.1 (110)
Some college 36.4 (209)
College grad 39.5 (227)
Marital status
Married 59.5 (342)
Not married 40.5 (233)
Current smokers
Yes 15.8
No 84.2
n Mean and standard deviation.
Grad, graduate; HS, high school.
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associated with eGFR decline. Table 4 contains the estimates of
the ﬁnal growth model. For the subgroup analysis, we did not
observe signiﬁcant association between psychosocial stress
and eGFR among any of the two subgroups. However, among
those whose eGFR values declined, the relationship was
marginally signiﬁcant (β¼0.161, P¼0.053) at study baseline.
Discussion
Changes in renal function have been associated with an
increased risk of mortality [38,39]. Variability exists in changes
in eGFR and may reﬂect in the variation in the onset and
progression of DN [40]. In the present study, we examined the
direct association between changes in eGFR and psychosocial
stress. We also examined other documented predictors of
eGFR decline among this study population.
Our primary hypothesis that psychosocial stress would be
associated with eGFR was not supported in the ﬁnal growth
model. We did not observe an evidence of a direct association
between psychosocial stress and eGFR. This null ﬁnding is
consistent with the ﬁndings from the unique study by
Tsurugano et al [41] that did not ﬁnd a direct association between
job stress and chronic kidney diseases (eGFRo60 mL/min/
1.73 m2). A number of reasons may partly explain the null
ﬁnding in the present study. First, psychosocial stress is a
broad concept, spanning multiple facets of life including major
life events, ﬁnancial circumstances, perceived discrimination,
social circumstances, and the work environment [42–44].
The present study included stress from two main sources—
the work environment and social settings in assessing the
psychosocial stress factor. It is therefore possible that the
current measure had underestimated the level of psychosocial
stress in this population. The measure might not have been
comprehensive enough to assess all stressful situations in
individuals that might predispose them to a decline in eGFR.
Second, although our study participants were DM patients,
they were relatively young (mean age of 49.9 years, standard
deviation¼6.9) and healthy without a major microvascular or
macrovascular complications at the time of the study in 2005.
The rate of decline of renal function increases with age with
the greatest decline noted among those aged 50–60 years
[45,46], which formed less than half of our study population.
Therefore, the changes in renal function in this population may
be slow. The 4-year follow-up may be too short to observe
signiﬁcant changes in eGFR, although a study with a median
follow-up period of 3.4 years noted signiﬁcant changes in eGFR
that was associated with risk of death [47]. Future studies
should consider a longer follow-up period or use one of the
sensitive markers of eGFR such as albuminuria or proteinuria,
both of which were not available in this study. Third, a major
predictor of decline of renal function among DM patients is
poor glycemic control. Goel and Perkins [48] demonstrated
that higher HbA1c increases eGFR loss. The Diabetes Control
and Complications Trial, the Epidemiology of Diabetes Inter-
vention and Complications study, and a number of other
studies also made similar ﬁndings of the association between
HbA1c and eGFR [7,49–51]. During the 4-year study period,
the mean HbA1c remained consistent with values ranging
between 7.9% and 8.1%. A marginal but signiﬁcant improve-
ment in eGFR was also observed among the study population.
Although unexpected, kidney function can be variable and
may improve over time [52,53]. Finally, the study participants
were in an integrated delivery system of well-established DM
management program and might have received special care to
prevent or slow eGFR decline [54]. Although no signiﬁcant
association was observed between depression and eGFR in the
subgroup analysis, the marginal P value (P¼0.053) observed
among those who experienced decline in eGFR warrants
further research. With only 173 individuals within this cate-
gory, future studies with larger sample size should further
explore this association.
Even though no direct association was observed between
psychosocial stress and changes in eGFR, some of the study
covariates were signiﬁcantly associated with eGFR in the
expected direction. This observed association validates the
data and identiﬁes factors that are important to changes in
eGFR among the study population, providing information that
could guide prevention efforts, especially for factors that can
be modiﬁed. At baseline, race, age, insulin use, and MAP was
each signiﬁcantly related to eGFR. Blacks had lower eGFR
values compared to their white counterparts. Racial differ-
ences in decline of renal function have been reported, with
blacks experiencing the greatest disparity compared to whites
[55,56]. Increasing age has been associated with eGFR decline
among adults with DM. Use of insulin was associated with
decline in eGFR which is consistent with the literature [30].
Insulin use may be related to having had DM for a long time,
and/or poor glycemic control, particularly, among type 2 DM
patients both factors of which have been associated with
Table 4. Covariates in the ﬁnal model
Variable Intercept (P)n SE (I) Slope (P) SE (S)
SES quartile 0.01 (0.994) 1.078 0.27 (0.398) 0.316
Education 1.29 (0.298) 1.242 0.04 (0.902) 0.344
Marital status (0¼NM) 0.91 (0.671) 2.129 0.69 (0.274) 0.63
Smoking 1.03 (0.724) 2.925 1.19 (0.184) 0.897
BMI 0.10 (0.486) 0.138 0.02 (0.592) 0.039
Insulin (0¼nonuse) 6.99 (0.003) 2.326 1.09 (0.127) 0.714
Medication coverage 0.71 (0.871) 4.39 1.28 (0.290) 1.208
MAP 0.24 (0.003) 0.08 –0.10 (<0.001) 0.026
Age 1.22 (<0.001) 0.159 0.02 (0.634) 0.048
Sex (0¼male) 0.66 (0.732) 1.913 0.30 (0.585) 0.545
Race (0¼black) 7.45 (<0.001) 2.088 0.05 (0.933) 0.614
n Mean ﬁt indices: χ2 P40.001; RMSEA¼0.048 (90% CI¼0.041–0.055); CFI¼0.902; TLI¼0.876; and SRMR¼0.037.
BMI, body mass index; CFI, comparative ﬁt index; CI, conﬁdence interval; NM, not married; MAP, mean arterial pressure; RMSEA, root mean square
error of approximation; SE (I), standard error of the intercept; SE (S), standard error of the slope; SES, socioeconomic status; SRMR, standardized root
mean square residual; TLI, Tucker Lewis index.
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decline of renal function among DM patients [8,57–59]. Con-
sistent with prior studies, increasing MAP was found to be
associated with eGFR at both study baseline and over time
[60–62]. Some interventional studies have demonstrated that
antihypertensive treatment among DM patients may reduce
the incidence or slow the progression of decline of renal
function [63,64]. As presented in Fig. 2, the effect of MAP on
eGFR trajectory during the study period indicated that not only
were people with higher MAP started with lower eGFR value
but their rate of decline was also faster.
The strengths of the study need to be noted. First, to the
best of our knowledge, this is the ﬁrst study to examine the
direct association between psychosocial stress as a latent
factor and renal function over time among individuals with
DM. The use of CFA in the measurement and quantiﬁcation of
stress is preferred because it explicitly accounts for differential
measurement error related to the different items, thus, yield-
ing a more accurate and precise assessment of the underlying
constructs [65,66]. The use of structural equation modeling
allowed for the utilization of the latent stress variable that was
created at the CFA step. Second, the study controlled for
several covariates that may impact renal function among
individuals with DM including HbA1c level, blood pressure,
smoking, medication coverage, and demographic variables.
The following points, however, need to be considered as study
limitations: (1) our measure of psychosocial stress may be
limited by the inclusion of fewer major sources of psychosocial
stress; (2) we did not have data on albumin, C-reactive protein,
and nutrition information which are important factors in renal
changes; and (3) participants were enrollees of the HMO, and
results may not be generalizable to uninsured patients, those
in other health insurance systems, or patients in other geo-
graphic locations.
In conclusion, in a study of fairly healthy adult DM patients,
we did not ﬁnd a direct association between psychosocial
stress and eGFR. However, predictors of changes in eGFR
included age, race, insulin use, and blood pressure. Interven-
tions to address decline of renal function among DM patients
should address high blood pressure. Considering the inclusion
of limited sources of psychosocial stress in creating the stress
factor and unavailability of other important covariates such as
albumin and C-reactive protein, we recommend that future
studies should address these limitations.
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